Morningstar Investment Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,466
Closed -$1.51M 376
2024
Q3
$1.51M Buy
2,466
+297
+14% +$176K 0.02% 187
2024
Q2
$1.2M Buy
2,169
+277
+15% +$159K 0.01% 190
2024
Q1
$1.1M Sell
1,892
-572
-23% -$321K 0.01% 183
2023
Q4
$1.31M Buy
2,464
+1,700
+223% +$823K 0.01% 210
2023
Q3
$384K Buy
764
+137
+22% +$73K ﹤0.01% 225
2023
Q2
$322K Buy
627
+131
+26% +$70.7K ﹤0.01% 214
2023
Q1
$278K Buy
496
+92
+23% +$51.9K ﹤0.01% 209
2022
Q4
$225K Buy
+404
New +$214K ﹤0.01% 211
2022
Q1
Sell
-342
Closed -$228K 254
2021
Q4
$228K Buy
+342
New +$214K ﹤0.01% 229

Other funds holding TMO

Morningstar Investment Services's TMO Position: Q4 2024 in Review

Morningstar Investment Services sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 2,466 shares — an estimated $1.51M sold.

Morningstar Investment Services first reported a position in TMO in Q4 2021 and held it in 9 quarters. The position peaked at $1.51M in Q3 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Morningstar Investment Services reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 2,466 Thermo Fisher Scientific shares in Q4 2024, an estimated $1.51M.
  • Morningstar Investment Services first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 9 quarters.
  • Morningstar Investment Services's Thermo Fisher Scientific position peaked at $1.51M in Q3 2024.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Morningstar Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.